Leaders in the healthcare sector, including the Philips Foundation, Johnson & Johnson Impact Ventures, Sanofi Global Health Unit’s Impact Fund, and MIT Solve Innovation Future, have contributed to the successful completion of the growth funding round for Egyptian startup Rology, an AI-assisted teleradiology platform.
In order to address the global shortage of radiologists, Amr Abodraiaa, Moaaz Hossam, Mahmoud Eldefrawy, and Bassam Khallaf founded Rology in October 2017. The company has developed a cloud-based platform that offers intelligent matchmaking between patients and remote radiologists.
Radiologists can work from anywhere in the world as long as they have access to a laptop and internet connection due to the startup’s technology, which can be launched with no setup costs for both hospitals and radiologists.
After completing a pre-Series A funding round in April 2022, Rology acquired Arkan United in 2023 to enter Saudi Arabia, which has the biggest healthcare industry in the region. After obtaining funding from investors like the Philips Foundation, Johnson & Johnson Impact Ventures, Sanofi Global Health Unit’s Impact Fund, and MIT Solve Innovation Future, it has also launched in Kenya and is now poised for additional expansion.
“This round brings together mission-aligned leaders across industry, research, and impact investing to advance AI reporting and expand access to high-quality radiology across MEA,” said Abodraiaa.
With a network of more than 200 radiologists and more than 1.2 million lives saved and more than 1.3 million radiology reports delivered to more than 300 hospitals in 13 countries, Rology has emerged as a vital infrastructure layer in healthcare systems throughout Africa and the Middle East, encompassing both private and public health institutions, including those in underserved and vulnerable areas.
With its end-to-end teleradiology platform and AI models, Rology tackles the pressing need for quicker, higher-quality diagnostics as radiologist shortages and rising imaging demand create bottlenecks worldwide. Its FDA 510(k) approved teleradiology system offers up to 25% cost savings on diagnostic reporting and excellent clinical accuracy (99.89%).
“As a follow-on lead investor, Philips Foundation reaffirms its confidence in Rology’s innovative model that bridges the diagnostic gap and strengthens access to quality care. This investment reflects our belief in human-centered technology that gives clinicians time back and makes advanced diagnostics available where they are needed most,” said Eddine Sarroukh, head of Philips Foundation.
“Supporting companies like Rology is central to our mission of advancing equitable access to healthcare by combining digital innovation with practical, system-level impact.”
